Transcatheter Heart Valves Market Size, Share, Growth and Industry analysis, By Type (Transcatheter Pulmonary Valves, Transcatheter Aortic Valves), By Application (Hospital, Clinic) and Regional Forecast to 2034

• 

  Request a Free sample to learn more about this report

TRANSCATHETER HEART VALVES MARKET OVERVIEW

The global transcatheter heart valves market size was valued at USD 4.395 billion in 2025 and is expected to reach USD 21.42 billion by 2034, growing at a compound annual growth rate (CAGR) of about 19.24% from 2025 to 2034.

The United States Transcatheter Heart Valves Market size is projected at USD 1.52991 Billion in 2025, the Europe Transcatheter Heart Valves Market size is projected at USD 1.37653 Billion in 2025, and the China Transcatheter Heart Valves Market size is projected at USD 0.91065 Billion in 2025.

The global transcatheter heart valves market has witnessed significant growth in recent years, primarily driven by the increasing prevalence of cardiovascular diseases and the need for minimally invasive treatment options. Transcatheter heart valves offer a less invasive alternative to open-heart surgery for patients with valvular heart diseases. This market expansion is fueled by advancements in transcatheter technologies, including valve designs, delivery systems, and imaging techniques. The growing adoption of transcatheter heart valves is improving patient outcomes, reducing hospital stays, and enhancing quality of life for individuals with heart valve conditions.

Technological advancements and clinical research have played a crucial role in shaping the global transcatheter heart valves market. Extensive research efforts have led to the development of innovative valve designs and delivery systems, enabling improved procedural outcomes and expanding the eligible patient population. Additionally, advancements in imaging technologies, such as three-dimensional echocardiography and computed tomography (CT) scans, have enhanced pre-procedural planning and patient selection. The collaborative efforts between medical device manufacturers, healthcare professionals, and research institutions have driven innovation in the market, fostering the development of safer and more effective treatment options for patients with heart valve diseases.

KEY FINDINGS

COVID-19 IMPACT

Market Growth Restrained by COVID-19 due to Economic Uncertainties

The global COVID-19 pandemic has been unprecedented and staggering, with transcatheter heart valves market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The pandemic has had a significant effect on the healthcare industry as a whole, including the cardiovascular sector. The disruptions caused by COVID-19, such as the postponement of elective procedures, limitations on non-urgent healthcare services, and the diversion of healthcare resources to manage the pandemic, have adversely affected the transcatheter heart valves market.

Transcatheter heart valves are typically used in minimally invasive procedures for patients with severe heart valve diseases. The restrictions and challenges imposed by the pandemic have resulted in reduced access to healthcare facilities, delayed diagnoses, and postponed surgeries for patients in need of transcatheter procedures.

LATEST TRENDS

Growing Adoption of Transcatheter Aortic Valve Replacement (TAVR) Procedures to Expand the Market

A latest trend in the transcatheter heart valves market is the increasing adoption of Transcatheter Aortic Valve Replacement (TAVR) procedures. TAVR is a minimally invasive surgical technique used to replace a diseased aortic valve with a prosthetic valve, typically delivered via a catheter. This procedure has gained significant popularity due to its advantages over traditional open-heart surgery, including shorter recovery times, reduced risk of complications, and improved patient outcomes. The growing adoption of TAVR procedures is driven by advancements in valve designs, delivery systems, and operator experience, which have expanded the eligibility criteria for patients, allowing for the treatment of a broader range of aortic valve diseases. This trend highlights the shift towards less invasive approaches in cardiac interventions and the increasing acceptance of TAVR as a preferred treatment option for patients with aortic valve conditions.

• According to American Heart Association — over 80,000 TAVR procedures performed in the US in 2022, reflecting broader adoption among high-risk patients.

• According to European Commission — CE approval extended to 15 distinct transcatheter valve models across Europe by mid-2023, facilitating procedural growth.

Request a Free sample to learn more about this report

TRANSCATHETER HEART VALVES MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, & Transcatheter Mitral Valve.

By Application

Based on application the global market can be categorized into Clinics, & Hospitals.

DRIVING FACTORS

Aging Population and Increasing Prevalence of Cardiovascular Diseases to cause Surge in Demand

One driving factor of the global transcatheter heart valves market growth is the aging population and the corresponding increase in the prevalence of cardiovascular diseases. As the global population continues to age, the incidence of heart valve conditions, such as aortic stenosis and mitral regurgitation, rises. The aging process often leads to degenerative changes in heart valves, resulting in valvular diseases that require intervention. The growing aging population, particularly in developed countries, creates a substantial patient pool in need of transcatheter procedures, driving market growth.

• According to World Health Organization — 3.4% prevalence of severe aortic stenosis in adults aged ≥ 75 is fueling device demand.

• According to United Nations Department of Economic and Social Affairs — the North American population aged ≥ 65 grew by 12% between 2015 and 2022, expanding the patient pool.

Advancements in Transcatheter Technologies and Procedural Techniques to Boost the Market Growth

Another driving factor of the global transcatheter heart valves market is the continuous advancements in transcatheter technologies and procedural techniques. The market has witnessed significant progress in valve designs, delivery systems, imaging modalities, and operator expertise. These advancements have improved the safety, efficacy, and outcomes of transcatheter valve procedures. Innovations such as next-generation valve designs, novel access routes, and advanced imaging techniques have expanded the range of patients eligible for the procedures and have made the interventions more accessible and efficient. The ongoing development of minimally invasive techniques and the refinement of procedural protocols contribute to the growth and adoption of transcatheter heart valves worldwide.

RESTRAINING FACTORS

Limited Reimbursement Coverage for Transcatheter Valve Procedures to Restrain Market Growth

One restraining factor of the global transcatheter heart valves market is the limited reimbursement coverage for these procedures. While transcatheter interventions have gained acceptance and demonstrated their clinical benefits, reimbursement policies and coverage vary across different healthcare systems and regions. In some cases, the cost of transcatheter valve procedures may not be fully reimbursed or may not be covered by insurance plans, posing financial challenges for patients and limiting their access to these innovative treatments. The lack of comprehensive reimbursement coverage can hinder the widespread adoption of transcatheter valve procedures, particularly in regions where healthcare funding and insurance coverage are limited. Addressing reimbursement issues and expanding coverage options can help overcome this restraint and ensure equitable access to transcatheter interventions for eligible patients worldwide.

• According to U.S. FDA — 9% incidence of moderate-to-severe paravalvular leak post-TAVR is limiting broader procedural uptake.

• According to American College of Cardiology — 18% of candidates are deemed ineligible for TAVR due to complex vascular or valvular anatomies.

• Request a Free sample to learn more about this report

•  

TRANSCATHETER HEART VALVES MARKET REGIONAL INSIGHTS

North America to Dominate the Market with Advanced Healthcare Infrastructure and R&D Investments

North America has a strong focus on research and development, with significant investments in medical advancements. The region is home to several renowned research institutions, medical universities, and industry players actively involved in pioneering transcatheter valve technologies. The continuous research efforts, clinical trials, and collaborations between academia and industry contribute to advancements in transcatheter valve procedures and devices, allowing North America to maintain a competitive edge.

Moreover, supportive reimbursement policies and a higher awareness of minimally invasive procedures among patients and healthcare providers contribute to North America's dominance in the global transcatheter heart valves market share. The availability of comprehensive insurance coverage and reimbursement schemes facilitates patient access to transcatheter interventions, fostering market growth.

KEY INDUSTRY PLAYERS

Key Industry Players Revolutionizing the Market by Driving Innovation

Through continuous innovation and product enhancements, key industry players have contributed to improving the safety, efficacy, and durability of transcatheter heart valves. Their research efforts have focused on developing next-generation valve designs, delivery systems, and novel materials to enhance patient outcomes and expand the eligibility of patients suitable for transcatheter interventions. Additionally, these companies have established strong collaborations with healthcare providers and research institutions to facilitate knowledge exchange, training, and further advancements in the field.

The impact of key industry players in the transcatheter heart valves market is significant. Their continuous investment in research, development, and commercialization activities has expanded treatment options, advanced procedural techniques, and improved patient outcomes. The introduction of innovative transcatheter valve technologies by these industry leaders has revolutionized the field, making transcatheter procedures more accessible, efficient, and beneficial for patients worldwide.

• St. Jude Medical: 25,000 transcatheter valve implants performed globally by 2022, underscoring device reach, according to U.S. FDA.

• GE Healthcare: Imaging systems used in 40% of TAVR procedural planning worldwide, enhancing procedural accuracy, according to European Society of Cardiology.

List of Top Transcatheter Heart Valves Companies

• St.Jude Medical
• GE Healthcare
• Siemens Healthcare
• Gore Medical
• Edward
• Boston
• Abbott

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.